TANG CAPITAL MANAGEMENT LLC - Q1 2015 holdings

$188 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 10 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 33.3% .

 Value Shares↓ Weighting
HRTX  HERON THERAPEUTICS INC$71,580,000
+44.6%
4,919,6250.0%38.07%
+40.3%
LJPC  LA JOLLA PHARMACEUTICAL CO$39,242,000
-0.8%
2,144,3870.0%20.87%
-3.8%
 OPKO HEALTH INCdebt 3.0% 2/1/33$29,439,000
+43.1%
14,000,0000.0%15.66%
+38.8%
BMRN  BIOMARIN PHARMACEUTICAL INC$22,718,000
+37.9%
182,3000.0%12.08%
+33.7%
MRTX BuyMIRATI THERAPEUTICS INC$11,392,000
+158.0%
388,543
+63.0%
6.06%
+150.3%
 MERRIMACK PHARMACEUTICALS INCnote 4.5% 7/15/20$11,154,000
+9.1%
5,500,0000.0%5.93%
+5.8%
OGXI BuyONCOGENEX PHARMACEUTICALS INC$1,351,000
+61.6%
628,400
+72.2%
0.72%
+57.0%
RXII NewRXI PHARMACEUTICALS CORP$1,132,0001,572,699
+100.0%
0.60%
HZNP ExitHORIZON PHARMA PLC$0-490,000
-100.0%
-3.46%
SLXP ExitSALIX PHARMACEUTICALS INC$0-300,000
-100.0%
-18.91%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HERON THERAPEUTICS INC37Q3 202355.0%
LA JOLLA PHARMACEUTICAL CO34Q2 202237.1%
ROCKET PHARMACEUTICALS INC20Q3 202331.6%
BIOMARIN PHARMACEUTICAL INC18Q3 201712.1%
ODONATE THERAPEUTICS INC17Q4 202169.8%
ANAPTYSBIO INC16Q3 202318.4%
COHERUS BIOSCIENCES INC15Q3 20232.7%
EQUILLIUM INC13Q3 20231.2%
RELMADA THERAPEUTICS INC12Q4 20226.2%
MIRATI THERAPEUTICS INC11Q3 202310.9%

View TANG CAPITAL MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
42024-02-14
42024-02-02
42023-12-18
13F-HR2023-11-14
42023-10-13
13F-HR2023-08-14
32023-06-01
42023-06-01
42023-05-30

View TANG CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export TANG CAPITAL MANAGEMENT LLC's holdings